Table of Content

1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Product Scope
1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Existing Drugs
1.2.3 Akynzeo (Netupitant-Palonosetron FDC)
1.2.4 Aloxi (Palonosetron)
1.2.5 Emend (Aprepitant)
1.2.6 Kytril Generic (Granisetron)
1.2.7 Zofran Generic (Ondansetron)
1.2.8 Pipeline Drugs
1.2.9 SUSTOL (Granisetron Injection extended release)
1.2.10 Rolapitant
1.3 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Trends (2016-2027)

2 Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Forecasts by Region
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027)
2.4.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027)
2.4.6 India Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027)

3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Competition Landscape by Players
3.1 Global Top Chemotherapy-Induced Nausea and Vomiting Drugs Players by Sales (2016-2021)
3.2 Global Top Chemotherapy-Induced Nausea and Vomiting Drugs Players by Revenue (2016-2021)
3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs as of 2020)
3.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2016-2021)
4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Type (2022-2027)

5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2016-2021)
5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Application (2022-2027)

6 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures
6.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company
6.1.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021)
6.1.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021)
6.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type
6.2.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application
6.3.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application (2022-2027)

7 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures
7.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company
7.1.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021)
7.1.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021)
7.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type
7.2.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application
7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures
8.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company
8.1.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021)
8.1.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021)
8.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type
8.2.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027)
8.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application
8.3.1 China 153 Sales Breakdown by Application (2016-2021)
8.3.2 China 153 Sales Breakdown by Application (2022-2027)

9 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures
9.1 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company
9.1.1 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021)
9.1.2 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021)
9.2 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type
9.2.1 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures
10.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company
10.1.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures
11.1 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company
11.1.1 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021)
11.1.2 India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021)
11.2 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type
11.2.1 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027)
11.3 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application
11.3.1 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Chemotherapy-Induced Nausea and Vomiting Drugs Business
12.1 Merck & Co., Inc.
12.1.1 Merck & Co., Inc. Corporation Information
12.1.2 Merck & Co., Inc. Business Overview
12.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
12.1.5 Merck & Co., Inc. Recent Development
12.2 GlaxoSmithKline plc
12.2.1 GlaxoSmithKline plc Corporation Information
12.2.2 GlaxoSmithKline plc Business Overview
12.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
12.2.5 GlaxoSmithKline plc Recent Development
12.3 Tesaro, Inc.
12.3.1 Tesaro, Inc. Corporation Information
12.3.2 Tesaro, Inc. Business Overview
12.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
12.3.5 Tesaro, Inc. Recent Development
12.4 Helsinn Group
12.4.1 Helsinn Group Corporation Information
12.4.2 Helsinn Group Business Overview
12.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
12.4.5 Helsinn Group Recent Development
12.5 F. Hoffmann-La Roche Ltd.
12.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.5.2 F. Hoffmann-La Roche Ltd. Business Overview
12.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
12.5.5 F. Hoffmann-La Roche Ltd. Recent Development
12.6 Heron Therapeutics, Inc.
12.6.1 Heron Therapeutics, Inc. Corporation Information
12.6.2 Heron Therapeutics, Inc. Business Overview
12.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
12.6.5 Heron Therapeutics, Inc. Recent Development
12.7 Dr. Reddy's Laboratories Ltd.
12.7.1 Dr. Reddy's Laboratories Ltd. Corporation Information
12.7.2 Dr. Reddy's Laboratories Ltd. Business Overview
12.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
12.7.5 Dr. Reddy's Laboratories Ltd. Recent Development
12.8 Acacia Pharma
12.8.1 Acacia Pharma Corporation Information
12.8.2 Acacia Pharma Business Overview
12.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
12.8.5 Acacia Pharma Recent Development
12.9 Sun Pharmaceutical Industry Ltd.
12.9.1 Sun Pharmaceutical Industry Ltd. Corporation Information
12.9.2 Sun Pharmaceutical Industry Ltd. Business Overview
12.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
12.9.5 Sun Pharmaceutical Industry Ltd. Recent Development
12.10 Otsuka Holdings Co., Ltd.
12.10.1 Otsuka Holdings Co., Ltd. Corporation Information
12.10.2 Otsuka Holdings Co., Ltd. Business Overview
12.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
12.10.5 Otsuka Holdings Co., Ltd. Recent Development

13 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Cost Analysis
13.1 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
13.4 Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List
14.3 Chemotherapy-Induced Nausea and Vomiting Drugs Customers

15 Market Dynamics
15.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends
15.2 Chemotherapy-Induced Nausea and Vomiting Drugs Drivers
15.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
15.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Region (2016-2021)
Table 8. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Company (2016-2021)
Table 14. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Company (2016-2021)
Table 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs as of 2020)
Table 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2016-2021)
Table 23. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2022-2027)
Table 26. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2022-2027)
Table 28. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Application (2016-2021)
Table 31. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Application (2022-2027)
Table 35. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Application (2022-2027)
Table 37. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027)
Table 62. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021)
Table 64. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021)
Table 68. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027)
Table 70. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021)
Table 72. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027)
Table 98. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021)
Table 100. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021)
Table 104. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027)
Table 106. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021)
Table 108. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027)
Table 110. Merck & Co., Inc. Corporation Information
Table 111. Merck & Co., Inc. Description and Business Overview
Table 112. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 114. Merck & Co., Inc. Recent Development
Table 115. GlaxoSmithKline plc Corporation Information
Table 116. GlaxoSmithKline plc Description and Business Overview
Table 117. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 119. GlaxoSmithKline plc Recent Development
Table 120. Tesaro, Inc. Corporation Information
Table 121. Tesaro, Inc. Description and Business Overview
Table 122. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 124. Tesaro, Inc. Recent Development
Table 125. Helsinn Group Corporation Information
Table 126. Helsinn Group Description and Business Overview
Table 127. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 129. Helsinn Group Recent Development
Table 130. F. Hoffmann-La Roche Ltd. Corporation Information
Table 131. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 132. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 134. F. Hoffmann-La Roche Ltd. Recent Development
Table 135. Heron Therapeutics, Inc. Corporation Information
Table 136. Heron Therapeutics, Inc. Description and Business Overview
Table 137. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 139. Heron Therapeutics, Inc. Recent Development
Table 140. Dr. Reddy's Laboratories Ltd. Corporation Information
Table 141. Dr. Reddy's Laboratories Ltd. Description and Business Overview
Table 142. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 144. Dr. Reddy's Laboratories Ltd. Recent Development
Table 145. Acacia Pharma Corporation Information
Table 146. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Acacia Pharma Description and Business Overview
Table 148. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 149. Acacia Pharma Recent Development
Table 150. Sun Pharmaceutical Industry Ltd. Corporation Information
Table 151. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Sun Pharmaceutical Industry Ltd. Description and Business Overview
Table 153. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 154. Sun Pharmaceutical Industry Ltd. Recent Development
Table 155. Otsuka Holdings Co., Ltd. Corporation Information
Table 156. Otsuka Holdings Co., Ltd. Description and Business Overview
Table 157. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 159. Otsuka Holdings Co., Ltd. Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List
Table 163. Chemotherapy-Induced Nausea and Vomiting Drugs Customers List
Table 164. Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends
Table 165. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
Table 166. Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
Table 167. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemotherapy-Induced Nausea and Vomiting Drugs Product Picture
Figure 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Existing Drugs Product Picture
Figure 4. Akynzeo (Netupitant-Palonosetron FDC) Product Picture
Figure 5. Aloxi (Palonosetron) Product Picture
Figure 6. Emend (Aprepitant) Product Picture
Figure 7. Kytril Generic (Granisetron) Product Picture
Figure 8. Zofran Generic (Ondansetron) Product Picture
Figure 9. Pipeline Drugs Product Picture
Figure 10. SUSTOL (Granisetron Injection extended release) Product Picture
Figure 11. Rolapitant Product Picture
Figure 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2021 & 2027
Figure 13. Serotonin Receptor Antagonists Examples
Figure 14. NK1 Receptor Antagonists Examples
Figure 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 18. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 19. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 20. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 21. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 23. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 27. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 31. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 32. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 33. Global 5 Largest Chemotherapy-Induced Nausea and Vomiting Drugs Players Market Share by Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs: 2016 & 2020
Figure 34. Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 35. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2016-2021)
Figure 36. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Application (2016-2021)
Figure 38. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020
Figure 40. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020
Figure 41. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020
Figure 42. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020
Figure 43. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020
Figure 44. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020
Figure 45. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020
Figure 46. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020
Figure 47. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020
Figure 48. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020
Figure 49. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020
Figure 50. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure 53. Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure 54. Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed